Expertise in
3
conditions

Greg R. Fulcher

Sydney, NSW, AU 
Expertise in
3
conditions
Sydney, NSW, AU 

Overview

Greg Fulcher practices practicing medicine in Sydney, Australia.

Mr. Fulcher is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Osmotic Diuresis, and Type 1 Diabetes (T1D).

He is actively involved in clinical research, co-authoring 37 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Sydney, NSW, Australia
Other Locations
The Royal North Shore Hospital, Reserve Road, St Leonards, NSW 2065, Australia
Royal North Shore Hospital And University Of Sydney, North Shore, NSW, Australia
Camperdown, NSW 2006, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomised Trial to Evaluate the Efficacy on Retinopathy and Safety of Fenofibrate in Adults With Type 1 Diabetes. A Multicentre Double-blind Placebo-controlled Study in Australia and Internationally.
A Randomised Trial to Evaluate the Efficacy on Retinopathy and Safety of Fenofibrate in Adults With Type 1 Diabetes. A Multicentre Double-blind Placebo-controlled Study in Australia and Internationally.
Enrollment Status: Active_not_recruiting
Publish Date: January 20, 2026
Intervention Type: Drug
Study Drug: Fenofibrate
Study Phase: Phase 3
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Glargine
Study Phase: Phase 3
View 1 Less Clinical Trial

37 Total Publications

Glucose levels at hospital admission are associated with 5 year mortality.
Glucose levels at hospital admission are associated with 5 year mortality.
Journal: Diabetes research and clinical practice
Published: May 22, 2024

Frequently Asked Questions about Greg R. Fulcher

Is Greg R. Fulcher a top-rated expert for Type 2 Diabetes (T2D)?

MediFind is an objective health platform that identifies experts based on real-world data. Greg R. Fulcher is classified as an Distinguished expert for Type 2 Diabetes (T2D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Greg R. Fulcher participate in research or clinical trials?

Yes. Greg R. Fulcher has published 37 articles and abstracts on conditions like Type 2 Diabetes (T2D). You can view a list of Greg R. Fulcher's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Fulcher's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile